Metabolon provides pharma, academic, and consumer institutions with critical and actionable information on the small molecules involved in metabolism

Metabolon is focused on the systematic measurement and biological interpretation of the low molecular weight (~50-1500 Da) metabolites within a biological sample. Metabolon is a commercial-stage metabolomics company exploring biomarker discovery and the development of innovative, cost-effective diagnostic tests.

Metabolon was founded in 2000 and maintains a 40,000 square foot headquarters and CLIA-certified, CAP-accredited lab in Research Triangle Park, North Carolina. The privately-held company employs ~150 people globally, with experts in the fields of biochemistry, mass spectrometry, and software development, and has conducted 4,000+ studies across therapeutic areas, 500+ of which have resulted in publications such as Nature, Cell, Science, and JCI.